E-therapeutics Plc
ETXPF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Market Cap | – | $95,570 | $104,714 | $162,720 |
| - Cash | $20,519 | $20,665 | $31,689 | $15,257 |
| + Debt | $0 | $710 | $295 | $922 |
| Enterprise Value | – | $75,615 | $73,320 | $148,385 |
| Revenue | $0 | $318 | $475 | $641 |
| % Growth | -100% | -33.1% | -25.9% | – |
| Gross Profit | $0 | $318 | $475 | $477 |
| % Margin | – | 100% | 100% | 74.4% |
| EBITDA | -$18,474 | -$13,723 | -$9,281 | -$9,522 |
| % Margin | – | -4,315.4% | -1,953.9% | -1,484.5% |
| Net Income | -$14,869 | -$11,166 | -$8,274 | -$10,848 |
| % Margin | – | -3,511.3% | -1,741.9% | -1,691.2% |
| EPS Diluted | -0.02 | -0.019 | -0.015 | -0.022 |
| % Growth | -5.2% | -24% | 30.6% | – |
| Operating Cash Flow | -$16,559 | -$10,897 | -$8,011 | -$10,419 |
| Capital Expenditures | -$410 | -$247 | -$259 | -$1,295 |
| Free Cash Flow | -$16,969 | -$11,144 | -$8,221 | -$11,714 |